American Heart Association Scientific Sessions OnDemand 2022

20 $

+ Include: 303 videos + 303 audios + 303 file sub vtt + 298 pdfs, size: 228 GB

+ Target Audience: cardiologists

Description

+ Include: 303 videos + 303 audios + 303 file sub vtt + 298 pdfs, size: 228 GB

+ Target Audience: cardiologists

+ Sample video: contact me for sample video

+ Information:

1. Overview

The American Heart Association Scientific Sessions OnDemand 2022 is a premier global cardiovascular conference that highlights the latest scientific advancements, late-breaking clinical trials, and emerging therapies in cardiovascular medicine. The course covers a comprehensive array of topics including heart failure, interventional cardiology, prevention, and basic cardiovascular sciences to improve patient care and outcomes.

Course Dates: November 5–7, 2022

2. Learning Objectives

  • Evaluate the latest late-breaking clinical trials and their direct implications for cardiovascular disease management.

  • Implement updated American Heart Association guidelines for the prevention and treatment of various cardiovascular conditions.

  • Analyze new pharmacological and interventional therapies for heart failure, arrhythmias, and structural heart diseases.

  • Discuss the impact of health equity, digital health innovations, and novel technologies on cardiovascular care delivery.

  • Integrate basic and translational cardiovascular science findings into multidisciplinary clinical practice.

3. Target Audience

Best for cardiologists, researchers, and cardiovascular clinicians who want updates on late-breaking trials, heart failure, and AHA guidelines.

4. Topics

  • 2022 State-of-the-Art Update on Salt and Hypertension  

  • 3CPR Shark Tank Session  

  • 3CPR Speed Mentoring  

  • 7 Questions About Cardiovascular Disease in Women 2022 Edition  

  • A Joint World Heart Federation (WHF) and AHA Session  

  • A Walk in the Park Turns Into a Fall in the Park_ The Underrecognized Problem of Falls Among Adults With CVD  

  • Achieving Equity in Diagnosis and Treatment of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy  

  • Acute Management of Arrhythmias in the Hospitalized Patient  

  • Adjunct Interventional Strategies for AF Management  

  • Advanced Imaging for Procedural Planning  

  • Advanced Technologies in Understanding Heart Failure  

  • Advancement in Cardiovascular Single Cell and Clonal Hematopoietic Biology  

  • Advances in Diabetes and Heart Failure_ From Bench to Bedside  

  • Advancing Health Equity and Inclusion in Lifestyle and Cardiometabolic Health Research  

  • AF Ablation for 2022 What’s New  

  • Age Friendly Care for the Older Adult With CVD and Stroke  

  • Aging and Cardiac Disease – Bench and Bedside Insights  

  • Ancel Keys Memorial Lecture  

  • Annual Update in Clinical Lipidology  

  • Are Social Determinants Permanent Going Beyond Observation to Intervention  

  • Arrhythmias and Heart Failure_ Breaking the Vicious Cycle  

  • At the Intersection of Intervention and Heart Failure  

  • Athero & Thrombo_ Reciprocal Regulation Between Lipids and the Hemostatic System  

  • Atrial Fibrillation and Cardioembolic Sources of Stroke a Continuous Challenge in Cerebral and Cardiovascular Disease  

  • Atrial Fibrillation_ What will be new in 2023 – AHA Joint Session with Heart Rhythm Society  

  • Battling It Out_ Controversies in Cardio-Renal Disease (Debates)  

  • Best in Science_ When AI Meets Cardiovascular Genomics  

  • Best Interventional Trials of 2022  

  • Best Practices and Guidelines for Cardiometabolic and Diabetes Care in 2022 A Flipped-Classroom Discussion With the Experts  

  • Beyond Statins_ Assessing and Addressing Residual Risk  

  • Beyond the Genetic Code_ The Role of Epigenetics in Pulmonary Hypertension  

  • Beyond the Heart_ Impact of CHD on Other Organ Systems Across the Lifespan  

  • Beyond the Pill_ Nonpharmacological Approaches in PAH  

  • Breaking the Mold for Carotid Imaging_ New Avenues in Diagnosis, Surveillance and Follow-Up  

  • Bridging Cardiology and Immunology  

  • Bridging the Chasm_ Gender, Racial and Socioeconomic Imbalances in Cardiovascular Disease  

  • Bringing Hope to Hopeless Cases  

  • Broad Perspectives in Metabolism  

  • Cardiac Arrhythmias in Patients With Kidney Disease- Finding the Right Rhythm  

  • Cardiac Myosin Inhibition, and its Role in the Landscape of Symptomatic NYHA Class II-III Obstructive HCM  

  • Cardiac Surgery and Atrial Fibrillation_ State of the Art  

  • Cardio-Nephrology as a Career Path What Does It Take  

  • Cardiovascular Disease in Diverse Immigrant Populations  

  • Cardiovascular Health for Cancer Survivors_ Advancing Preventive Cardio-Oncology  

  • Cardiovascular Medicine Relevant Updates in the Guidelines for the Prevention of Stroke in Patients With Stroke and TIA  

  • Cardiovascular Nano & Molecular Medicine_ Delivering on the Promise  

  • Career Transitions Success Stories from Two Academic Families  

  • Case-Based Session in Structural Heart Disease (TEER, TAVI, PFO)  

  • Challenges and Opportunities for Recruitment and Retention for Studies Involving Participant Enrollment  

  • Challenges and Solutions for Women and Underrepresented Persons Working in Hypertension Science  

  • Challenging Atrial Arrhythmias in the EP Lab A Case-Based Discussion  

  • Changing Views on Rhythm Control_ Is Earlier Better for Improving Outcomes in AF Patients_  

  • Charles T. Dotter Memorial Lecture  

  • Chronotherapy_ Non-Pharmacologic and Pharmacologic Interventions to Improve Circadian Blood Pressure  

  • Circulation Research_ 2022 Highlights and Initiatives  

  • Circulation_ Innovation in Cardiovascular Science and Medicine_ Part 1  

  • Circulation_ Innovation in Cardiovascular Science and Medicine_ Part 2  

  • Clinical and Surgical Management of End-Stage PAH  

  • Clinical Cardiovascular Genetics Boot Camp (Pre-Registration Required)  

  • Clinical Controversies and Technical Tips in Tavi_ A 2022 Perspective  

  • Clinical Debates in Cardiovascular Genetics  

  • Clinical Trials in Pulmonary Hypertension_ Novel Biomarkers and Endpoints  

  • Confronting the Epidemic of Amputations in Underserved Diabetic Populations  

  • Congenital Heart Research & Innovation 2022 and Beyond Power in Numbers Updates on CHD Clinical Trials and Multicenter Studies  

  • Consensus and Controversies_ Debating the 2021 ACC_AHA_SCAI Guidelines for Coronary Revascularization  

  • Contribution of Cardiovascular Disease to Brain Health and Cognition  

  • Controversies in Antithrombotic Therapy After Cerebrovascular Events  

  • Controversies in RV Dysfunction and Management_ A Pro-Con Debate  

  • Controversies in SAVR vs TAVR in European vs American Guidelines  

  • Controversies in the Cardiovascular Care of Young Athletes  

  • Conversations in Cholesterol Efflux_ How Can We Harness its Cardioprotective Potential_  

  • Cournand and Comroe Early Career Investigator Award Competition  

  • COVID-19 and the Pediatric Heart  

  • Critical Care Cardiology in Older Adults_ Too Little, Too Much, Too Late  

  • Cross-Specialty Approaches to Problems in Congenital Heart Disease and Pediatric Cardiology  

  • Crosstalk of Metabolic Pathways With Heart Failure Cell Signaling  

  • CRRT in the Cardiac Critical Care Setting_ An Overview for the Cardiologist  

  • CV Prevention at Every Opportunity_ Individual and Environmental Interventions  

  • CVRI Boot Camp (Pre-Registration Required)  

  • CVSA Early Career Investigator Abstract Award  

  • Developmental Pathways That Impact Cardiac Disease  

  • Dickinson W. Richards Memorial Lecture  

  • Did You Know Learn Novel Hypertension Research Discoveries  

  • Digital Health Equity Leveraging Informatics Interventions to Close the Gap in Health Outcomes for Patients with Cardiac Conditions  

  • Disparities in Multifactorial Cardiovascular Risk Reduction in Diabetes_ Know Diabetes by Heart and Beyond  

  • Doubly Disadvantaged_ Considerations for Cardiovascular Care Among Older Adults Across Gender and Racial Groups  

  • Dyspnea in Obesity_ When is It Heart Failure_  

  • Early Career CVSA – Pitfalls and Pearls  

  • Early Career EP  

  • Effect of Marijuana on Cardiovascular and Brain Health  

  • Elaine W. Raines Early Career Investigator Award Competition  

  • Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training Competition  

  • EP Potpourri  

  • Evaluation of Renal Dysfunction and Shared Decision-Making of Advanced Cardio-Renal Therapies in Advanced Heart Failure  

  • Evolution of Critical Care Cardiology and the State-of-the-Art Contemporary Cardiac Intensive Care Unit  

  • Exerkines_ Mediators of Health and Disease  

  • Expanding Horizons in Vasculo-Oncology  

  • Expert Perspectives on the Management of Patients with CAD and_or PAD  

  • Fibroblasts and Fibrosis_ From Molecular Mechanisms to Actionable Targets  

  • Following Her Heart Across the Lifespan_ Cardiovascular Disease in Pregnancy & How Health Disparities Impact Maternal Mortality  

  • Forging Your Path – Building Careers in Cardio-Oncology  

  • Fostering the Future of Hispanic Health  

  • From Bench to Bedside_ A Potpourri of Novel Concepts in Cardio-Oncology  

  • From Deep Learning to Neural Networks_ The Use of Artificial Intelligence to Detect Cardiovascular Disease  

  • Frontiers in Science_ Arrhythmia Research Summit – Advances in Digital Health and Artificial Intelligence in Arrhythmia Management  

  • Frontiers in Science_ Arrhythmia Research Summit – Evaluation and Management of Syncope and Cardiac Dysautonomias_ A 2022 Update  

  • Frontiers in Science_ Arrhythmia Research Summit – Inherited Arrhythmias A 2022 Update  

  • Frontiers in Science_ Arrhythmia Research Summit – Novel Imaging Modalities from Bench to Bedside  

  • Frontiers in Science_ Arrhythmia Research Summit Bench to Bedside Translating New Players in Arrhythmogenesis  

  • Frontiers in Science_ Arrhythmia Research Summit Bench to Bedside_ Translating New Approaches to AF Ablation  

  • Frontiers in Science_ Atherosclerosis, Thrombosis and Vascular Biology Blood Clots in Infections – Were We Ready for COVID-19  

  • Frontiers in Science_ Atherosclerosis, Thrombosis and Vascular Biology_ The Battle of the Lipoproteins_ What Is Driving Residual  

  • Frontiers in Science_ Vascular Disease – Bringing Novel Devices to Patients  

  • Frontiers in Science_ Vascular Disease – Unmet Needs in Post-Thrombotic Syndrome_ Spotlight on Mechanisms, Outcomes and Therapies  

  • Genetic Therapies Are the Future of Treating Cardiomyopathy  

  • Genomic and Precision Medicine Early Career Investigator Award Competition  

  • George Lyman Duff Memorial Lecture  

  • GETTING TO THE HEART OF THE MATTER_ Management of CV risk in patients with CKD associated with T2D  

  • Great Debates in Cardiovascular Quality of Care  

  • Harmonizing US and European Blood Pressure Guidelines to Focus on Decreasing Global Cardiovascular Risk – AHA Joint Session  

  • Health Disparities Across The Heart Failure Disease Spectrum A Way Forward  

  • Health Technology Used to Effectively and Efficiently Run Real-World Efficacy Studies and Analysis  

  • Heart and Kidney Outcomes Trials_ A Deep Dive into Trial Design  

  • Heart-Neurons Interplay in Health and Disease  

  • Help Your MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI  

  • Hiding in Plain Sight_ Identification and Management of ATTR-CM Patients  

  • Highlighting the Achievements of Our ATVB Young Members  

  • Hot Debates in Heart Failure Diagnosis and Management  

  • Hot Topics in Acute Coronary Syndrome  

  • How can LEQVIO (inclisiran) help certain patients  

  • How to Perform Physiologic Pacing  

  • Hypertension Across the Lifespan in Women  

  • Identifying and Practicing Emerging Genomic Based Therapies on Cardiovascular Disease  

  • Imaging Wisely in Cardiac Amyloid_ How to Add Value in This New HFpEF Era  

  • Immuno-Oncological Therapies and Cardiovascular Health  

  • Implementable Guidelines and Health Technology to Effectively Operationalize Them  

  • Implementing Machine Learning for Precision Care_ Crossing the Bridge to Reality  

  • Improving Cardiovascular Disease Prevention in Latin America and the Caribbean Joint Session of the InterAmerican Heart Foundation  

  • Improving Cardiovascular Health Outcomes Through Real-World Science  

  • Improving Diversity in the Congenital Heart Disease Workforce  

  • In-depth and Fresh Look in Heart Failure Trials  

  • Inflammation and Cardiovascular Complications in Patients With Kidney Disease  

  • Inflammation and Metabolic Signals in Cardiometabolic Disease  

  • Inflammatory Mechanisms of Cardiac Disease  

  • Influence of Metabolism on Cardiac Function and Remodeling  

  • Inter- and Intragenerational Transmission of Cardiovascular Disease Risk_ Does Family Matter_  

  • Intersection of Kidney and Heart Failure – Biomarkers, Treatment and Outcomes in Patients With Cardiorenal Disease  

  • Interventional Central_ CHIP Deep Dive_ As Good as It Gets!  

  • Interventional Theater_ Case Presentation and Discussion Revascularization Guidelines to Practice  

  • Introduction to Single-Cell and Spatial Omics  

  • Is the Burden of Symptomatic Chronic HFrEF Inevitable_ Defining and recognizing early signs or symptoms of WHF  

  • Ischemic Heart Disease and ACS in Women_ The Usual and the Unusual  

  • Jardiance (empagliflozin) tablets A Review of the Latest Data  

  • Jay D. Coffman Early Career Investigator Award Competition  

  • Katharine Lembright Award and Lecture_Martha N. Hill New Investigator Award  

  • Kathleen A. Dracup Mentoring Award Lecture and Fireside Chat With Legends in Nursing  

  • Kenneth D. Bloch Memorial Lecture in Vascular Biology  

  • Kidney Dysfunction – Culprit in Heart Failure with Preserved Ejection Fraction_  

  • Laennec Clinician-Educator Award & Lecture  

  • Laennec Fellow In Training (Fit) Clinician Award Competition  

  • Late-Breaking Basic Science Oral Abstracts 1  

  • Late-Breaking Basic Science Oral Abstracts 2  

  • Late-Breaking Science_ Breakthrough Strategies in the HF Journey  

  • Late-Breaking Science_ The Main Event_ Changing Clinical Practice – Remote Presenter_ Daniel Levy  

  • Leveraging Health Technology to Support Smoking Cessation  

  • Life’s Essential 8_ AHA’s Enhanced Approach to Measuring, Monitoring and Modifying Cardiovascular Health  

  • Linkages Between Biomarkers and Patient-Reported Outcomes  

  • Lipids, Lipid Mediators and Lipoprotein Metabolism  

  • Living Your Best Life_ Targeting Equity in Palliative Care  

  • Louis N. and Arnold M. Katz Basic Science Research Prize for Early Career Investigators Competition  

  • Machine Learning, Biosensors, and Virtual Reality in CHD_ The Future Is Now  

  • Making the Learning Health System a Reality  

  • Managing Complex Procedures in Cardiovascular Medicine- AHA Joint Session with Israel Heart Society  

  • Marshalling the Promise of mHealth to Reduce Cardiovascular Disease Risk  

  • Mechanical Complications After Acute Myocardial Infarction_ What Do You Need to Know in 2022_  

  • Mechanism and Treatment of Lymphatic Diseases, Lipedema and Related Diseases  

  • Mechanisms of Right Ventricular Cardiomyopathy  

  • Meet the Expert in Cardiovascular Disease_ Basic Science  

  • Meet the Expert in Cardiovascular Disease_ Clinical Science  

  • Meet the Expert in Cardiovascular Disease_ Population Science  

  • Meet the Experts in Cardiogenic Shock  

  • Meet the Trialist_ EMPA-KIDNEY  

  • Meet the Trialist_ RAPID  

  • Melvin Judkins Early Career Clinical Investigator Award Competition  

  • Melvin L. Marcus Early Career Investigator Award in Cardiovascular Sciences Competition  

  • Mind the Gap_ Providing Optimal Cardiac Care for Patients in Life Transitions  

  • Mitral Valve Repairs and Replacements in 2022_ Open Surgical and Transcatheter Approaches  

  • Modern Cardio-Oncology_ From Mechanisms to Imaging  

  • Molecular Targets in Oncology Driving Cardiovascular Discovery and Therapy  

  • More Than Plaque Rupture_ Our Evolving Understanding of the Pathophysiology of ACS  

  • Moving the Needle on Global Hypertension Control Rates_ Putting Into Practice What We Know  

  • Multimodality Imaging in Chest Pain_ What, When and to Which Patients  

  • Myocardial Injury After Noncardiac Surgery  

  • Mythbusters_ What Do You Really Know About Complementary and Alternative Medicines in HF Management_  

  • Neurocardiology Pearls in Stroke Care_ Practical Management and Controversies  

  • Neurocardiology_ At the Intersection Between Cardiology and Stroke, an AHA-WSO Symposium  

  • New Advances in the Use of Polygenic Risk Scores in Clinical Practice  

  • New Contributors to Arrhythmia Mechanisms  

  • New Frontiers in Intracoronary Imaging and Physiology  

  • New Ideas in Cardiac Tissue Engineering  

  • New Insights Into Endothelial Dysfunction in Cardiovascular Disease  

  • Novel Aspects of Lipoprotein Composition and Function  

  • Novel Biomarker Utilization in Stable and Unstable CAD  

  • Novel Experimental Approaches for Arrhythmia Management and Risk Assessment  

  • Novel Insights in Hypertension Control and Management From Intervention Studies  

  • Novel Omics-Derived Insights Into the Pathogenesis of Pulmonary Arterial Hypertension  

  • Novel Regulation of Vascular Smooth Muscle Cell Function in Atherosclerosis  

  • Novel Therapeutics in Heart Failure  

  • Novel Tools for Clinical Decisions in Arrhythmic Disorders  

  • Observational and Clinical Trials in Nutrition  

  • Opening Session Moving Science into Public Health Lessons Learned Session Description US Surgeon Generals & International Public Health  

  • Overcoming Career Challenges Due to COVID-19  

  • Overcoming Challenges in Congenital Valve Disease  

  • Patient-Centered Models of Care_ How Are We Doing_  

  • Paul Dudley White International Lecture and Session_ Laurate, Storytelling and Perspectives for Syndemic and Global Cardiovascular  

  • Pecha Kucha Says It Is in the Genes  

  • Pediatric Obesity, the Next Frontier in Determinants of Health  

  • Percutaneous and Surgical Interventions for Ischemic and Structural Heart Disease in Heart Failure Patients Which has Superior Outcomes  

  • Peripheral Artery Disease – A Matter of Life and Limb  

  • Periprocedural Kidney Function Optimization_ A Converging Point for Nephrology and Interventional Cardiology  

  • Picture Worth a Thousand Words Image Guidance of Cardiac Valve Interventions  

  • Precision Health in Cardiovascular Nursing Science_ Prevention and Management of Cardiometabolic Health in Marginalized Populations  

  • Preclinical Testing of Bioengineered Cell and Tissue Therapies for Cardiovascular Diseases  

  • Pregnancy Complications and Cardiovascular Outcomes  

  • Pulmonary Vascular Emergencies in the CICU  

  • Quest Diagnostics and Steve Rusckowski Early Career Investigator Award for Preventive Cardiovascular Medicine Research  

  • Racial Disparities in Cardiovascular and Kidney Disease  

  • Rapid-Fire, Interdisciplinary, Actively-Moderated Case Discussions in Cardio-Metabolic Disorders  

  • Recent Advances in Device Therapy in Cardiac Disease- AHA Joint Session with Japanese Circulation Society  

  • Reconciling the Acute Chest Pain Guidelines Enabling AI Prediction of CV Risk  

  • Regenerative and Gene-Based Therapies for Pediatric Heart Disease  

  • Rethinking the Approach_ Management of Elevated LDL-C in Patients With ASCVD  

  • Rising to the Challenge of Aortic Disease in Pregnant Women  

  • Risk Stratification for Atherosclerotic CV Disease_ Utility of Risk Factors and Non-Invasive Testing  

  • Risk Stratification in Congenital Heart Disease and Pediatric Cardiology  

  • RNA Biology in Heart Failure  

  • Russell Ross Memorial Lectureship in Vascular Biology  

  • Samuel A. Levine Early Career Clinical Investigator Award Competition  

  • Seeing With a Functional Lens in Cardiovascular Research  

  • Shared Decision-Making_ Partnering to Improve Cardiovascular Health  

  • Sinus Tachycardia and POTS – Insights Into Mechanisms and Management  

  • Sol Sherry Distinguished Lecture in Thrombosis  

  • Solving the Heart Attack Crisis with Next Generation Plaque Analysis  

  • Special Focus on Lipoproteina From Biology to Therapy AHA Joint Session with American Society for Preventive Cardiology  

  • Special Topics in Fellow to Faculty Transition in Clinical Cardiology  

  • State of the Art Cardiovascular Care Atrial Fibrillation, Stroke and Heart Failure  

  • State of the Art Cardiovascular Care Primary Prevention of Cardiovascular Disease and Updates on COVID-19  

  • State of the Art Cardiovascular Care_ Updates in Interventional Structural Heart Disease  

  • State of the Art in Understanding the Genetics and Genomics of Cardiac Disease  

  • State of the Art Updates on the Management of CLTI  

  • State of the Art_ Cardiomyopathy  

  • State-of-the-Art Pulmonary Vascular Translational Science  

  • Stroke Risk From a Systemic Cardiovascular Perspective – New Scientific Developments  

  • Structural Case Theater – State of the Art Cases in Structural Interventions  

  • Successful Lifestyle Strategies and Novel Blood Pressure Measurement Technologies for Hypertension Control  

  • Surgical Therapy of Structural Heart Disease Oral Abstracts  

  • T. Duckett Jones Memorial Lecture and Outstanding Research Awards in Pediatric Cardiology  

  • Targeting LDL-C in ASCVD Patients_ Are We There Yet_  

  • Targeting Non-Coding RNAs for Cardiovascular Therapeutics  

  • Targeting the Mitochondria in the Ischemic Myocardium  

  • Team Science as an Early Career Investigator Teamwork Makes the Dream Work  

  • Technology and Health Care Delivery Innovation  

  • Temporary Mechanical Circulatory Support_ When, Why and How  

  • The ‘Epidemic of Epidemics’ – Intersectionality of Cardiometabolic Diseases and Social Inequalities from a Syndemic Perspective  

  • The 6th Link_ From Cardiac Arrest Survival to Developing Interventions for Optimal Survivorship  

  • The Cutting Edge of Thoracic Aortic Disease Management_ Updates and Controversies  

  • The ECG_ New Information From an Old Test  

  • The European Heart Journals Year in Cardiovascular Medicine Joint Symposium of the European Heart Journal  

  • The Evolving Landscape of Lipid Management  

  • The Great Debate_ Current Topics In Cardio-Oncology  

  • The Heart and the Kidney_ Why Can’t They Just Get Along_  

  • The Modern Vascular Clinic Practice_ Optimizing Pad Outcomes  

  • The Patient in Diabetes_ From Mechanism to Trials and on to Management  

  • The Right Intervention in the Right Patient at the Right Time_ Optimizing Outcomes in Cardiogenic Shock  

  • The Right Ventricle Carries the Load_ Right Ventricular Pathophysiology in Pulmonary Hypertension  

  • The Role of Antiarrhythmic Drugs in Early Rhythm Control and the Management of Atrial Fibrillation  

  • The Role of Omics in Vaccine Development_ Implications for Cardiovascular Health  

  • The Science of Cardiovascular Symptoms  

  • The Story of Goldilocks and the Three Advanced Heart Failure Patients Not Too Late, Not Too Early, the Just Right Time  

  • The Times They Are A-Changin_ Controversies in Anticoagulation for Venous Thromboembolism  

  • To Boldly Go! The Next Frontier in PE Clinical Trials  

  • Trained Immunity and Inflammation in Atherosclerosis  

  • Treating Recurrent Pericarditis and Preventing Recurrence  

  • Treatment Considerations for Patients with HFrEF and Select Updates From the 2022 HF Guideline  

  • Update on 2022 Cardiovascular Clinical Guidelines  

  • Update on HFpEF_ We Actually Have Treatments  

  • Utilizing Registries to Investigate Vascular Disease  

  • Vascular Complications of COVID_ Much Ado About Everything  

  • Vascular Smooth Muscle Cell Phenotypic Modulation in Vascular Disease and Aging  

  • Vasoplegia and Cardiac Surgery  

  • Ventricular Tachycardia Ablation_ What’s New for 2022_  

  • Visualizing COVID for the Long Haul_ Heart-Vasculature-Brain  

  • Vivien Thomas Early Career Investigator Award Competition  

  • Wearable Devices to Improve Cardiovascular Disease Outcomes  

  • Wearable Health Tech and the Impact of Future Practice Patterns  

  • Weaving Antiracism and Equity Into the Fabric of Cardiovascular Fellowship Training  

  • What’s New With Making New Hearts_  

  • Whats New in the Management of Uncontrolled Resistant Hypertension  

  • When to Follow Adult Guidelines in Pediatric Care and When to Diverge  

  • Who Is Behind the Wheel Drivers of Heart Failure Self-Care and Outcomes_  

  • William W.L. Glenn Lecture  

  • Young Hearts Early Career Investigator Competition  

  • Young Hearts Mentor & Mentee Panel Discussion Cultivating a Symbiotic Relationship

Reviews

There are no reviews yet.

Be the first to review “American Heart Association Scientific Sessions OnDemand 2022”

Your email address will not be published. Required fields are marked *

12 + = 14
Powered by MathCaptcha